[HTML][HTML] The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J van Riet, HJG van de Werken, E Cuppen… - Nature …, 2021 - nature.com
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and
genetically heterogeneous malignancies, characterized by distinct prognoses based upon …

[PDF][PDF] The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J van Riet, HJG van de Werken, E Cuppen… - scholar.archive.org
Results Overview of included patients within the CPCT-02 aNEN cohort and whole-genome
sequencing. A total of 108 patients, originally classified as having a neuroendocrine …

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J Riet, HJG Werken, E Cuppen… - Nature …, 2021 - ideas.repec.org
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and
genetically heterogeneous malignancies, characterized by distinct prognoses based upon …

[PDF][PDF] The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J van Riet, HJG van de Werken, E Cuppen… - researchgate.net
Results Overview of included patients within the CPCT-02 aNEN cohort and whole-genome
sequencing. A total of 108 patients, originally classified as having a neuroendocrine …

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J van Riet, HJG van de Werken, E Cuppen… - Nature …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Metastatic and locally-advanced
neuroendocrine neoplasms (aNEN) form clinically and genetically heterogeneous …

[PDF][PDF] The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J van Riet, HJG van de Werken, E Cuppen… - repub.eur.nl
Results Overview of included patients within the CPCT-02 aNEN cohort and whole-genome
sequencing. A total of 108 patients, originally classified as having a neuroendocrine …

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets.

J van Riet, HJG van de Werken… - Nature …, 2021 - search.ebscohost.com
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and
genetically heterogeneous malignancies, characterized by distinct prognoses based upon …

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J Riet, HJG Werken, E Cuppen… - Nature …, 2021 - econpapers.repec.org
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and
genetically heterogeneous malignancies, characterized by distinct prognoses based upon …

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J van Riet, HJG van de Werken… - Nature …, 2021 - inrepo02.dkfz.de
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically
andgenetically heterogeneous malignancies, characterized by distinct prognoses based …

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

J van Riet, HJG van de Werken… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Metastatic and locally-advanced neuroendocrine neoplasms (aNEN) form clinically and
genetically heterogeneous malignancies, characterized by distinct prognoses based upon …